New hope for bile duct cancer: drug duo targets tough tumors
Disease control
Not yet recruiting
This phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy) and pucotenlimab (an immunotherapy)—in 30 adults with advanced biliary tract cancer whose first treatment stopped working. The goal is to see if the combo can shrink tumors and improve sur…
Phase: PHASE2 • Sponsor: HuiKai Li • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC